Last reviewed · How we verify
NCT07151066: PF
Anthropometric Parameters of the Foot and Plantar Fasciitis
trial in Plantar Fasciitis in 30 participants. Enrolling by invitation.
30 October 2025
Quick facts
| Lead sponsor | Medipol University |
|---|---|
| Status | ENROLLING BY INVITATION |
| Study type | OBSERVATIONAL |
| Enrollment | 30 |
| Start date | 15 December 2024 |
| Primary completion | 30 October 2025 |
| Estimated completion | 30 December 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Conditions studied
- Plantar Fasciitis — all drugs for Plantar Fasciitis →
Sponsor
Medipol University
Who can join
Adults 18 to 65, any sex, with Plantar Fasciitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to systematically evaluate anthropometric and lifestyle parameters in individuals diagnosed with PF and compare them with healthy individuals. This will reveal the structural and behavioural risk factors involved in the development of PF, providing a scientific basis for preventive measures and orthotic approaches. Assessment Parameters: Medical History Form 1. Demographic data: Age, height, weight, BMI 2. Foot anthropometric measurements 3. Footwear preference: Footwear Assessment Score ( Footwear Assessment Score ) 4. Lower extremity joint health: History of pain, injury, or limitation in the knee and hip joints 5. Daily step count: Measurement using the Step Counter mobile application 6. Physical activity level: IPAQ-SF (International Physical Activity Questionnaire - Short Form) questionnaire
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07151066
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Plantar Fasciitis
Currently open trials in the same condition.
- NCT07294196 — Percutaneous Electrolysis Targeting the Muscle-Fascia Chain for Treating Chronic Plantar Fasciitis in Adults · NA · recruiting
- NCT07463794 — Comparison of Extracorporeal Shock Wave Therapy and Whole Body Vibration Therapy in Plantar Fasciitis · NA · active not recruiting
- NCT07383558 — Effect of Additional Sural Nerve PRF in Chronic Heel Pain · recruiting
- NCT07242729 — Bone Marrow Aspirate Versus Platelet-Rich Fibrin for the Treatment of Chronic Plantar Fasciitis · NA · recruiting
- NCT06967168 — HeEL Pain Pathways Feasibility Study · NA · recruiting
Other Medipol University trials
Trials by the same sponsor.
- NCT07277803 — Device-Based vs Manual Sensory Training in Low Back Pain · NA · not yet recruiting
- NCT07214636 — Development and Investigation of the ApneaTheraPlay · NA · not yet recruiting
- NCT07534475 — Venous Tourniquet vs. Arterial Tourniquet for Seizure Monitoring in ECT · NA · not yet recruiting
- NCT07534488 — Sacral Erector Spinae Plane Block in Pilonidal Sinus Surgery · NA · not yet recruiting
- NCT07525648 — Comparison of the Effects of Sevoflurane and Desflurane on Optic Nerve Sheath Diameter During Laparoscopic Surgery · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07151066 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medipol University
- Last refreshed: 3 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07151066.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing